<p dir="ltr">Artificial intelligence (AI), precision oncology, and regenerative medicine are reshaping the global pharmaceutical industry, triggering an intensifying race among drugmakers such as Bayer, Roche, Novartis, Pfizer, Merck & Co., and AstraZeneca to develop faster, more targeted, and potentially curative treatments.</p>